Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
1663P Proof of concept study of low-dose nivolumab in cancers with unresectable cutaneous squamous cell carcinoma
Gilles Thibault, M. Amini Adle, E.M. Neidhardt, Romain Varnier, Serge Aho, Pierre-Étienne Heudel, Jean Yves Blay, J. Fayette (2025). 1663P Proof of concept study of low-dose nivolumab in cancers with unresectable cutaneous squamous cell carcinoma. , 36, DOI: https://doi.org/10.1016/j.annonc.2025.08.2291.
Article64 days agoClinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study
Mina Fazel, Romain Varnier, Hélène Vanacker, Nicolas Penel, Sarah Watson, Benjamin Verret, Thibaud Valentin, Emmanuelle Bompas, Waïsse Waïssi, Alexandra Meurgey, Françoise Ducimetière, Jean Yves Blay, Armelle Dufresne, Mehdi Brahmi (2025). Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study. , 131(18), DOI: https://doi.org/10.1002/cncr.70052.
Article64 days ago89P IMmunotherapy response associated clinical and biological PREdictive factors in advanced SARComas: A retrospective multicenter study
Mina Fazel, Romain Varnier, Jean Yves Blay, Mehdi Brahmi (2024). 89P IMmunotherapy response associated clinical and biological PREdictive factors in advanced SARComas: A retrospective multicenter study. , 9, DOI: https://doi.org/10.1016/j.esmoop.2024.102478.
Article64 days ago89P IMmunotherapy response associated clinical and biological PREdictive factors in advanced SARComas: A retrospective multicenter study
Mina Fazel, Romain Varnier, Jean Yves Blay, Mehdi Brahmi (2024). 89P IMmunotherapy response associated clinical and biological PREdictive factors in advanced SARComas: A retrospective multicenter study. , 9, DOI: https://doi.org/10.1016/j.esmoop.2024.102478.
Article64 days agoHyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
Romain Varnier, Thibaut Garrivier, Émilie Hafliger, Aymeric Favre, Clélia Coutzac, Clément Spire, Pauline Rochefort, Matthieu Sarabi, Françoise Desseigne, Pierre Guibert, Anne Cattey-Javouhey, Paméla Funk-Debleds, Charles Mastier, Adrien Buisson, David Pérol, Oliver Trédan, Jean Yves Blay, Jean-Marc Phélip, Christelle de la Fouchardière (2021). Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report. , 11, DOI: https://doi.org/10.3389/fonc.2021.756365.
Article59 days ago